about
Treatment of Cushing disease: overview and recent findingsAcromegaly pathogenesis and treatmentAdvancing Treatment of Pituitary Adenomas through Targeted Molecular Therapies: The Acromegaly and Cushing Disease ParadigmsInterpreting biochemical control response rates with first-generation somatostatin analogues in acromegalyNeed for improved monitoring in patients with acromegalyThe effects of somatostatin analogue therapy on pituitary tumor volume in patients with acromegalyPlace of preoperative treatment of acromegaly with somatostatin analog on surgical outcome: a systematic review and meta-analysisMeta-analysis on the effects of octreotide on tumor mass in acromegalyAcromegaly without imaging evidence of pituitary adenoma.Metabolic glucose status and pituitary pathology portend therapeutic outcomes in acromegaly.Tumor shrinkage with lanreotide Autogel 120 mg as primary therapy in acromegaly: results of a prospective multicenter clinical trial.Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guidelineRapid and sustained reduction of serum growth hormone and insulin-like growth factor-1 in patients with acromegaly receiving lanreotide Autogel therapy: a randomized, placebo-controlled, multicenter study with a 52 week open extensionPegvisomant in acromegaly: an update.Medical treatment of Cushing's disease: Overview and recent findings.Clinical efficacy and safety results for dose escalation of somatostatin receptor ligands in patients with acromegaly: a literature review.Management of acromegaly in Latin America: expert panel recommendationsMicrostructural brain changes in acromegaly: quantitative analysis by diffusion tensor imaging.Polycythemia as rare secondary direct manifestation of acromegaly: management and single-centre epidemiological data.Benign and malignant nodular thyroid disease in acromegaly. Is a routine thyroid ultrasound evaluation advisable?Use of Pegvisomant in acromegaly. An Italian Society of Endocrinology guidelineEstrogen treatment for acromegaly.Expert consensus document: A consensus on the medical treatment of acromegaly.Estrogens and selective estrogen receptor modulators in acromegaly.Clinical applications of somatostatin analogs for growth hormone-secreting pituitary adenomasOutcome of endoscopic transsphenoidal surgery in combination with somatostatin analogues in patients with growth hormone producing pituitary adenoma.Attenuated RORC expression in the presence of EMT progression in somatotroph adenomas following treatment with somatostatin analogs is associated with poor clinical recoveryClinical experiences and success rates of acromegaly treatment: the single center results of 62 patients.Increased prevalence of colorectal polyp in acromegaly patients: a case-control study.Growth hormone tumor histological subtypes predict response to surgical and medical therapy.Clinical, quality of life, and economic value of acromegaly disease controlEffects of fulvestrant on biological activity and Wnt expression in rat GH3 cells.Plasma proteomic profiles of bovine growth hormone transgenic mice as they age.Identification of somatostatin receptor type 5 gene polymorphisms associated with acromegalyAcromegaly with cardiomyopathy, cardiac thrombus and hemorrhagic cerebral infarct: a case report of therapeutic dilemma with review of literature.Pasireotide LAR maintains inhibition of GH and IGF-1 in patients with acromegaly for up to 25 months: results from the blinded extension phase of a randomized, double-blind, multicenter, Phase III study.Change in quality of life in patients with acromegaly after treatment with octreotide LAR: first application of AcroQoL in Korea.Treatment Options in Cushing's Disease.TSH-secreting pituitary adenoma: benefits of pre-operative octreotide.Medical therapy of acromegaly
P2860
Q24626819-5C4D248D-61AD-4C7A-BD68-E63A1009E64EQ24647360-8E6C69F2-C258-451F-B8F1-B1A2AC413AA3Q26741707-D0D93589-5259-4873-B2C4-83102BE7C09BQ26777682-B0346B14-5875-40D2-A54C-46945A999E94Q26783670-E6E0A6C9-F33B-4278-8B0E-6E488975DD28Q26796357-B8EB65AF-E683-46D1-B1A8-E70409E9F2A2Q27693237-4BC387BD-A1D0-4286-A30C-04243F88D0CDQ28730120-844A82E9-17E0-4C7C-9215-6F2EF3FECC6DQ30430884-0182BF91-6D4E-439C-BEA6-7DD6CF849409Q31139308-2657E917-ED1C-47CF-9407-DFF0D5047B14Q33564399-F483E909-452B-4A13-BE17-5BF1BDFA0690Q33587845-531DC916-8947-4DE2-A24A-1A7CEC94A4FBQ33595081-556EC79D-05BE-42D5-9DD1-5B3DC46A59B6Q33725999-A8F5A1E3-ABA3-468A-97DF-85D10B3C05C2Q33735039-875A7799-2C9F-4A88-8E2C-E8BAE037432CQ33772673-72F94F3D-5400-44DB-82E6-C21B800C15D4Q33794388-E8BE8E70-5686-4A48-A7E0-BA59AC623C7BQ33823168-0A4BBD2F-BA51-4B53-B71D-053C15B518CFQ33876612-732FD65A-188F-45CF-ACA7-10881B702E87Q34050636-4ECCD4CC-6D1A-4B94-8EB0-ACF2703F6FB5Q34277844-29403B50-CAA8-4565-886A-E93B04188C73Q34296660-869AA379-394B-4CA4-A973-119CD17D2364Q34406566-1480C856-D8E8-492B-B31C-282421BBC7D0Q34541969-AC8EB250-9046-4F6D-B1E6-9CA520AB55C9Q34658946-DB149546-FFCF-4E3B-8607-E73666AF7C13Q34749853-10C8A1D8-216F-46BE-96AC-897730EE31C8Q34794452-954454D9-8903-4523-A132-EB245D941FD8Q34901376-3622A167-BCCD-4F93-8873-3CCE7A6034BCQ34968263-FD628E4B-E2E2-445A-9A6D-C57D865CE62BQ35091578-657DB99F-7765-41DD-9F9B-CD1E537D341AQ35137675-CC0A18B5-747E-4440-A2F2-E8057CE1E815Q35157707-751DD456-E4FA-4AA1-B300-48375EEE086CQ35223799-55753F65-FA69-4028-A97A-F5D016A96A17Q35228807-F7A911B5-515A-42F3-8930-1C14662E812BQ35428187-C1912FDC-1BB6-46CE-875A-759EF97258B0Q35582894-DD33953E-D947-4666-A8B9-36F5F1A34EE2Q35740478-EF38633B-1701-4B44-ABB5-80F7885BEF6EQ35740882-68F1B884-E53A-4B30-AA20-2F013DDB621FQ35769172-BA8FC1C2-9EAA-4ADA-9666-101ED85F1F0FQ35895856-B074BDE1-64B1-4692-872E-E5377CD20CA4
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Guidelines for acromegaly management: an update.
@en
Guidelines for acromegaly management: an update.
@nl
type
label
Guidelines for acromegaly management: an update.
@en
Guidelines for acromegaly management: an update.
@nl
prefLabel
Guidelines for acromegaly management: an update.
@en
Guidelines for acromegaly management: an update.
@nl
P2093
P356
P1476
Guidelines for acromegaly management: an update.
@en
P2093
A B Grossman
A Giustina
Acromegaly Consensus Group
D Clemmons
D Kleinberg
P304
P356
10.1210/JC.2008-2421
P407
P577
2009-02-10T00:00:00Z